Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics ($LXEO), sold shares on the open market six times over the past year for a total of about $65,000. His latest sale occurred on February 18, 2026. These transactions rank 10,098th among 11,678 insiders, well below the average sale value of $8.6 million across about six trades per insider. Otero recorded no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Operating Officer | A | Common Stock | 5930 | $2.64 | 131,390.0000 | 72,987,327 | 4.73% | 0.01% |
| Nov. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Operating Officer | S | Common Stock | 721 | $9.27 | 63,476.0000 | 72,987,327 | 1.12% | 0.00% |
| Feb. 18, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Operating Officer | S | Common Stock | 3016 | $6.40 | 125,460.0000 | 72,987,327 | 2.35% | 0.00% |
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Operating Officer | A | Common Stock | 65000 | $0.00 | 128,476.0000 | 72,987,327 | 102.40% | 0.09% |
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Operating Officer | A | Stock Option (right to buy) | 260000 | $0.00 | 260,000.0000 | 72,987,327 | 9999.99% | 0.36% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | S | Common Stock | 721 | $9.27 | 63,476.0000 | 33,196,997 | 1.12% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | S | Common Stock | 24 | $9.56 | 64,197.0000 | 33,196,997 | 0.04% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | S | Common Stock | 2091 | $8.94 | 64,221.0000 | 33,196,997 | 3.15% | 0.01% |
| Oct. 15, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Common Stock | 5940 | $0.00 | 66,312.0000 | 33,196,997 | 9.84% | 0.02% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | S | Common Stock | 2848 | $4.67 | 60,372.0000 | 33,196,997 | 4.50% | 0.01% |
| March 14, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Common Stock | 5720 | $2.61 | 63,220.0000 | 0 | 9.95% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Common Stock | 26250 | $0.00 | 57,500.0000 | 0 | 84.00% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Stock Option (right to buy) | 52500 | $0.00 | 52,500.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Common Stock | 31250 | $0.00 | 31,250.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Otero Jose Manuel | Chief Technical Officer | A | Stock Option (Right to Buy) | 187500 | $0.00 | 187,500.0000 | 0 | 9999.99% | 0.00% |